380 related articles for article (PubMed ID: 11001938)
1. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
[TBL] [Abstract][Full Text] [Related]
2. Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies.
Bönnemann CG; Finkel RS
Semin Pediatr Neurol; 2002 Jun; 9(2):81-99. PubMed ID: 12139001
[TBL] [Abstract][Full Text] [Related]
3. Muscular dystrophies.
Nishino I; Ozawa E
Curr Opin Neurol; 2002 Oct; 15(5):539-44. PubMed ID: 12351997
[TBL] [Abstract][Full Text] [Related]
4. Dystroglycan is not required for localization of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin alpha 7B expression and caveolin-3 distribution.
Côté PD; Moukhles H; Carbonetto S
J Biol Chem; 2002 Feb; 277(7):4672-9. PubMed ID: 11741881
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex.
Galbiati F; Volonte D; Minetti C; Chu JB; Lisanti MP
J Biol Chem; 1999 Sep; 274(36):25632-41. PubMed ID: 10464299
[TBL] [Abstract][Full Text] [Related]
6. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models.
Durbeej M; Campbell KP
Curr Opin Genet Dev; 2002 Jun; 12(3):349-61. PubMed ID: 12076680
[TBL] [Abstract][Full Text] [Related]
7. Caveolae and caveolin-3 in muscular dystrophy.
Galbiati F; Razani B; Lisanti MP
Trends Mol Med; 2001 Oct; 7(10):435-41. PubMed ID: 11597517
[TBL] [Abstract][Full Text] [Related]
8. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
Aravamudan B; Volonte D; Ramani R; Gursoy E; Lisanti MP; London B; Galbiati F
Hum Mol Genet; 2003 Nov; 12(21):2777-88. PubMed ID: 12966035
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2).
Duggan DJ; Manchester D; Stears KP; Mathews DJ; Hart C; Hoffman EP
Neurogenetics; 1997 May; 1(1):49-58. PubMed ID: 10735275
[TBL] [Abstract][Full Text] [Related]
10. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.
Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH
Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985
[TBL] [Abstract][Full Text] [Related]
11. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3.
Galbiati F; Volonte D; Minetti C; Bregman DB; Lisanti MP
J Biol Chem; 2000 Dec; 275(48):37702-11. PubMed ID: 10973975
[TBL] [Abstract][Full Text] [Related]
12. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
Smythe GM; Eby JC; Disatnik MH; Rando TA
J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
[TBL] [Abstract][Full Text] [Related]
13. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
Crosbie RH; Barresi R; Campbell KP
FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
[TBL] [Abstract][Full Text] [Related]
14. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.
Volonte D; Peoples AJ; Galbiati F
Mol Biol Cell; 2003 Oct; 14(10):4075-88. PubMed ID: 14517320
[TBL] [Abstract][Full Text] [Related]
15. Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene.
Figarella-Branger D; Pouget J; Bernard R; Krahn M; Fernandez C; Lévy N; Pellissier JF
Neurology; 2003 Aug; 61(4):562-4. PubMed ID: 12939441
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.
Minetti C; Sotgia F; Bruno C; Scartezzini P; Broda P; Bado M; Masetti E; Mazzocco M; Egeo A; Donati MA; Volonte D; Galbiati F; Cordone G; Bricarelli FD; Lisanti MP; Zara F
Nat Genet; 1998 Apr; 18(4):365-8. PubMed ID: 9537420
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
Brockington M; Blake DJ; Prandini P; Brown SC; Torelli S; Benson MA; Ponting CP; Estournet B; Romero NB; Mercuri E; Voit T; Sewry CA; Guicheney P; Muntoni F
Am J Hum Genet; 2001 Dec; 69(6):1198-209. PubMed ID: 11592034
[TBL] [Abstract][Full Text] [Related]
18. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex.
Sciandra F; Bozzi M; Bianchi M; Pavoni E; Giardina B; Brancaccio A
Ann Ist Super Sanita; 2003; 39(2):173-81. PubMed ID: 14587215
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-3 deficiency causes muscle degeneration in mice.
Hagiwara Y; Sasaoka T; Araishi K; Imamura M; Yorifuji H; Nonaka I; Ozawa E; Kikuchi T
Hum Mol Genet; 2000 Dec; 9(20):3047-54. PubMed ID: 11115849
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.
Galbiati F; Engelman JA; Volonte D; Zhang XL; Minetti C; Li M; Hou H; Kneitz B; Edelmann W; Lisanti MP
J Biol Chem; 2001 Jun; 276(24):21425-33. PubMed ID: 11259414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
